-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Abbott Laboratories, Lowers Price Target to $125

Benzinga·07/28/2026 19:15:30
Listen to the news
UBS analyst Patrick Wood maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $135 to $125.